# Inactivated Hepatitis A Virus Vaccine

## Hepatitis A vaccine(Government) 0.5mL/dose

##### 

| TAH Drug Code      | IHAV0                                                                                                      |
|:-------------------|:-----------------------------------------------------------------------------------------------------------|
| Indications        | Active immunisation against infections caused by hepatitis A virus.                                        |
| Dosing             | IM, 0.5mL, 12 months-15 years primary immunization. A booster dose after 6-36 months.                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                              |
| Contraindications  | Hypersensitivity.                                                                                          |
| Adverse Effects    | Inj site soreness, mild redness & swelling, headache, malaise, vomiting, fever, nausea & loss of appetite. |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                              |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                              |

## HAVRIX 1440， 1mL/dose (Private)

##### 

| TAH Drug Code      | IHAV1                                                                                                      |
|:-------------------|:-----------------------------------------------------------------------------------------------------------|
| Indications        | Active immunisation against infections caused by hepatitis A virus.                                        |
| Dosing             | IM, 0.5mL, > or = 19 years primary immunization. A booster dose after 6-12 months.                         |
| Hepatic Impairment | Dose adjustment not necessary                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                              |
| Contraindications  | Hypersensitivity.                                                                                          |
| Adverse Effects    | Inj site soreness, mild redness & swelling, headache, malaise, vomiting, fever, nausea & loss of appetite. |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                              |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                              |

## Havrix 720 Junior 0.5mL/dose (Private)

##### 

| TAH Drug Code      | IHAV7                                                                                                                                                                                              |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Active immunisation against infections caused by hepatitis A virus.                                                                                                                                |
| Dosing             | Children & adolescents 1-18 yr Primary immunisation: A single IM dose. A booster dose at any time between 6 & 12 mth after the single dose is recommended in order to ensure long-term protection. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                      |
| Contraindications  | Hypersensitivity.                                                                                                                                                                                  |
| Adverse Effects    | Inj site soreness, mild redness & swelling, headache, malaise, vomiting, fever, nausea & loss of appetite.                                                                                         |
| Pregnancy          | No Data                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                      |

